Isoniazid resistance among rifampicin-susceptible Mycobacterium tuberculosis isolates from tuberculosis patients

Objective/Background: With the introduction of novel molecular techniques that rely on rifampicin (RIF) susceptibility, resistance to isoniazid (INH) or other first-line drugs remains undetected. Such patients are prescribed first-line antituberculosis therapy and are on RIF monodrug therapy during...

Full description

Bibliographic Details
Main Authors: Jyoti Arora, Ritu Singhal, Ajoy Kumar Verma, Gavish Kumar, Manpreet Bhalla, Rohit Sarin, Vithal Prasad Myneedu
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2016-01-01
Series:International Journal of Mycobacteriology
Subjects:
Online Access:http://www.ijmyco.org/article.asp?issn=2212-5531;year=2016;volume=5;issue=5;spage=127;epage=128;aulast=Arora